GLP-1s are changing US healthcare, should everyone be on them? GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.Share this: $elling $kinny: How a weight-loss startup kept shipping risky diet drugs while patients landed in the hospitalDateSeptember 3, 2026In relation toKing 5 NewsWhy Seattle waste drivers aren’t getting pricked like sanitation workers in New York (but you should still dispose of your needles in a safer way)DateSeptember 2, 2026In relation toCapitol Hill SeattleThe tragic toll of Sudan’s destroyed healthcareDateMarch 24, 2026In relation toAl-Jazeera